APOE and Cognitive impairment: Neuronal hyperactivity has been detected in patients with mild cognitive impairment, a prodromal stage of AD, and in carriers of the APOE4 allele, the most important genetic risk factor for late-onset sporadic AD, as well as in many transgenic AD mice (Hector and Brouillette, 2020).